Gereltuya Dorj

S.Zorig Street, 14210
Ulan Bator, Mongolia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Enhancing access to treatment and programmes for viral hepatitis in an endemic country: a narrative review of literature from 2000 to 2025 (Mongolia).

Enhancing access to treatment and programmes for viral hepatitis in an endemic country: a narrative review of literature from 2000 to 2025 (Mongolia).

Journal: Journal of pharmaceutical policy and practice
Published: April 22, 2026

Market landscape of penicillin for syphilis and rheumatic heart disease, WHO South-East Asia Region.

Market landscape of penicillin for syphilis and rheumatic heart disease, WHO South-East Asia Region.

Journal: Bulletin of the World Health Organization
Published: October 01, 2025

TB-related stigma is widely prevalent among people with TB and carers in Mongolia.

TB-related stigma is widely prevalent among people with TB and carers in Mongolia.

Journal: IJTLD open
Published: March 10, 2025

Denominator Matters: Comparing the Impact of Estimated Resident Population Versus Medicare Enrolment Population on Healthcare Utilisation Analyses.

Denominator Matters: Comparing the Impact of Estimated Resident Population Versus Medicare Enrolment Population on Healthcare Utilisation Analyses.

Journal: Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals
Published: January 28, 2025

Prevalence and risk factors of COVID-19 co-infection in TB patients.

Prevalence and risk factors of COVID-19 co-infection in TB patients.

Journal: IJTLD open
Published: January 09, 2025

Ensuring access to novel COVID-19 therapeutics in Pacific island countries and areas.

Ensuring access to novel COVID-19 therapeutics in Pacific island countries and areas.

Journal: Western Pacific surveillance and response journal : WPSAR
Published: July 21, 2023

Pharmacists as patient advocates: A series of case studies illustrating the impacts of a regular pharmacist service in residential aged care (nursing homes).

Pharmacists as patient advocates: A series of case studies illustrating the impacts of a regular pharmacist service in residential aged care (nursing homes).

Journal: Exploratory research in clinical and social pharmacy
Published: March 19, 2023

Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial.

Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial.

Journal: Drugs & aging
Published: December 19, 2022

Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial.

Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial.

Journal: Drugs & aging
Published: October 12, 2022

Frailty trajectory over one year among residential aged care (nursing home) residents.

Frailty trajectory over one year among residential aged care (nursing home) residents.

Journal: Frontiers in medicine
Published: August 04, 2022

Medicine-related problems: A recurrent issue among residents living in nursing homes.

Medicine-related problems: A recurrent issue among residents living in nursing homes.

Journal: Frontiers in pharmacology
Published: June 26, 2022

Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial).

Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial).

Journal: Age and ageing
Published: October 21, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026